Posted by Richard Willett - Memes and headline comments by David Icke Posted on 12 May 2022

BMJ’s Peter Doshi Tells FDA About Serious Concerns Over Pfizer Trial Data and Lack of FDA Oversight

Dr. Peter Doshi is an editor at the British Medical Journal (“BMJ”).  He dialled in to the most recent FDA committee meeting on vaccines and related biological products to give them his views regarding the integrity of the Pfizer “vaccine” trials.

On 2 November 2021, the BMJ published information disclosed to them by whistle-blower Brook Jackson, a former regional director for Ventavia Research Group.  Ventavia is a company that was contracted by Pfizer to help with the decisive trial.

Jackson provided BMJ with company documents, audio recordings, emails and photographs to support her claims.  She told BMJ: “The company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial.”

I have written a few posts about Dr. Peter Doshi as he seems to be a man of integrity, reporting on issues that most mainstream publications don’t or won’t. Dr Doshi is an associate professor of pharmaceutical health at the University of Maryland School of Pharmacy, as well as a senior editor at the British Medical Journal. “His research focuses on the drug approval process, how the risks and benefits of medical products are communicated, and improving the credibility and accuracy of evidence synthesis and biomedical publications.”

In the most recent US Food and Drug Administration (“FDA”) Vaccines and Related Biological Products Advisory Committee meeting in the US, 6 April 2022, Dr. Doshi dialled into the Open Public Hearing Session. This is where members of the public can present their own information to the FDA. The committee was meeting to discuss considerations for the use of Covid vaccine boosters and the process for Covid vaccine strain selection to address current and emerging variants.

Dr. Doshi told the FDA about Brook Jackson, a whistle-blower from Ventavia, which ran Pfizer’s vaccine trials. He discussed how unblinding of trial participants seems to have occurred and how this creates serious concerns about data integrity. Dr. Doshi also highlighted the lack of FDA inspection.

Read More: BMJ’s Peter Doshi Tells FDA About Serious Concerns Over Pfizer Trial Data and Lack of FDA Oversight


From our advertisers